About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Active Not RecruitingPhase 2

REVIVE: Replens Versus Intra-Vaginal Estrogen for the Treatment of Vaginal Dryness on Aromatase Inhibitor Therapy

NCT01984138•Polly A. Niravath, MD

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Estrogen Receptor Positive Breast CancerBreast Cancer

Interventions

ESTRING

Replens

+1 more

Locations

1

United States

Locations (1)

Houston Methodist Cancer Center

Houston, Texas, United States

Key Dates

Start Date

September 1, 2013

Primary Completion Date

June 3, 2025

Completion Date

June 1, 2026

Last Updated

January 28, 2026

Related Studies

Preoperative Sleep Quality and Postoperative Outcomes in Breast Surgery

NCT07547774

Breast CancerPostoperative Pain+1 more

A Pilot Trial of "Just ASK™" to Increase Discussions About Breast Cancer Clinical Trials

NCT07040891

RECRUITINGPhase 1

A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors

NCT06257264

Breast CancerSmall Cell Lung Cancer+10 more

RECRUITINGPhase 2

Reinvigorating TNBC Response to Immunotherapy With Combination Myeloid Inhibition and Radiation

NCT05491226

TNBC - Triple-Negative Breast CancerBreast Cancer

Study to Evaluate the Impact of the Use of Alternative and Complementary Therapies on Therapeutic Adherence in Patients Treated With taMoxifen for Early Stage Breast Cancer

NCT04740697

A Study to Evaluate the Effectiveness and Safety of Inavolisib in Participants With Endocrine-resistant, PIK3CA-mutated, Hormone Receptor-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer

NCT07347600

Locally Advanced Breast CancerMetastatic Breast Cancer

View all related studies

Sponsors

Lead Sponsor

Polly A. Niravath, MD

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 28, 2026Data synced to Clareo: April 27, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions